tiprankstipranks
Trending News
More News >
Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR
Advertisement

Arrowhead Pharmaceuticals (ARWR) Revenue

Compare
1,559 Followers

Arrowhead Pharmaceuticals Revenue

Arrowhead Pharmaceuticals had a revenue of 27.77M in the quarter ending Sep 30, 2025, with -94.88%. This bring the company's revenue in the last twelve months to 596.57M, Decreased 4.88%. In the fiscal year ending Dec 31, 2024, Arrowhead Pharmaceuticals had annual revenue of 3.55M with -98.52% growth.
Revenue (ttm)
596.57M
Revenue Growth
2816.21%
P/S Ratio
830.48
Revenue/Employee
$5,831
Employees
609
Market Cap
$2.95B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
3.55M-237.18M-98.52%
Dec 31, 2023
240.74M-2.50M-1.03%
Dec 31, 2022
243.23M104.94M+75.89%
Dec 31, 2021
138.29M50.30M+57.16%
Dec 31, 2020
87.99M-80.80M-47.87%
Dec 31, 2019
168.80M152.65M+945.67%
Dec 31, 2018
16.14M-15.27M-48.60%
Dec 31, 2017
31.41M31.25M+19,736.49%
Dec 31, 2016
158.33K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis